Alterations in Serotonergic Functions in Cocaine Addicts - 1

This study has been completed.

Sponsors and Collaborators:	National Institute on Drug Abuse (NIDA) Department of Veterans Affairs
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000312

Purpose

The purpose of this study is to evaluate alterations in the serotonergic system in cocaine addicts and attempt to dissociate changes secondary to cocaine use from those associated with premorbid characteristics.

Condition	Intervention	Phase
Cocaine-Related Disorders	Drug: M-CPP	Phase I

Drug Information available for: 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- Cocaine hydrochloride

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment
Official Title:	Alterations in Serotonergic Functions in Cocaine Addicts

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Side effects
Neuroendocrine changes
Psychological changes
Craving

Estimated Enrollment:

Eligibility

Ages Eligible for Study:	25 Years to 50 Years
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000312

Locations

United States, New York
VA Medical Center
Brooklyn, New York, United States, 11209

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

Department of Veterans Affairs

Investigators

Principal Investigator:

Laure Buydens-Branchey, M.D.

Department of Veterans Affairs

More Information

Study ID Numbers:	NIDA-09468-1, R01-09468-1
Study First Received:	September 20, 1999
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00000312
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Cocaine-Related Disorders
Mental Disorders
Substance-Related Disorders
Disorders of Environmental Origin
Cocaine

ClinicalTrials.gov processed this record on January 15, 2009